Methods and compositions for generating oligodendrocyte progenitor cells
US-2024158744-A1 · May 16, 2024 · US
US9574176B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9574176-B2 |
| Application number | US-201314436206-A |
| Country | US |
| Kind code | B2 |
| Filing date | Oct 29, 2013 |
| Priority date | Oct 31, 2012 |
| Publication date | Feb 21, 2017 |
| Grant date | Feb 21, 2017 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention provides a neural stem cell having increased passage ability and a method for manufacturing a neural stem cell having increased passage ability. A neural stem cell in which the N-type calcium channel gene is knocked out or the influx of Ca2+ via the N-type calcium channel is substantially absent can be passaged for at least 4 generations and maintains the differentiation potential into a nerve cell even after passage for 4 generations.
Opening claim text (preview).
The invention claimed is: 1. A neural stem cell having the following characteristics: (a) function or expression of the N-type calcium channel is knocked out in the cell, (b) influx of Ca2+ via the N-type calcium channel is substantially absent when function or expression of the N-type calcium channel is knocked out in the cell, (c) the cell can be passaged for at least 4 generations, and (d) the cell maintains differentiation potential into a nerve cell after passage for 4 generations. 2. The neural stem cell according to claim 1 , wherein the gene encoding the α1B subunit of the N-type calcium channel is knocked out. 3. The neural stem cell according to claim 1 , wherein the neural stem cell is nestin-positive after passage for 4 generations. 4. The neural stem cell according to claim 1 , wherein the neural stem cell has high proliferation ability and high sphere-forming ability after passage for 4 generations. 5. The neural stem cell according to claim 1 , wherein function or expression of the N-type calcium channel is knocked out by contacting the neural stem cell with an agent that inhibits function or expression of the N-type calcium channel. 6. The neural stem cell according to claim 5 , wherein the agent is ω-conotoxin GVIA. 7. A method for manufacturing a neural stem cell, wherein the method comprises: (A) a step of preparing a neural stem cell in vitro, and (B) a step of knocking out function or expression of the N-type calcium channel of the neural stem cell in vitro, wherein the manufactured neural stem cell has the following characteristics: (a) function or expression of the N-type calcium channel is knocked out in the cell, (b) influx of Ca2+ via the N-type calcium channel is substantially absent when function or expression of the N-type calcium channel is knocked out in the cell, (c) the cell can be passaged for at least 4 generations, and (d) the cell maintains differentiation potential into a nerve cell after passage for 4 generations. 8. The method for manufacturing a neural stem cell according to claim 7 , wherein the neural stem cell in step (A) is a cell derived from a human. 9. The method for manufacturing a neural stem cell according to claim 7 , wherein the neural stem cell in step (A) is a neural stem cell prepared by differentiation induction of an embryonic stem (ES) or induced pluripotent stem (iPS) cell into a neural stem cell. 10. The method for manufacturing a neural stem cell according to claim 7 , wherein the gene encoding the α1B subunit of the N-type calcium channel is knocked out. 11. The method for manufacturing a neural stem cell according to claim 7 , wherein function or expression of the N-type calcium channel is knocked out by contacting the neural stem cell with an agent that inhibits function or expression of the N-type calcium channel. 12. The method for manufacturing a neural stem cell according to claim 11 , wherein the agent is ω-conotoxin GVIA.
Cell cycle regulated proteins, e.g. cyclins, cyclin-dependant kinases · CPC title
Calcium; Ca chelators; Calcitonin · CPC title
Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells · CPC title
for animal cells · CPC title
Stem cells · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.